BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, April 16, 2026
Breaking News: Best of BioWorld Science: Q1Breaking News: Best of BioWorld: Q1Breaking News: Best of BioWorld: Q1
Home » Topics » BioWorld Science

BioWorld Science
BioWorld Science RSS Feed RSS

Endocrine/Metabolic

First preclinical data for M-012, a gene therapy to treat Gaucher disease

Oct. 18, 2022
Gaucher disease is a rare genetic metabolic...
Read More
Woman in crowd with anxiety
Biomarkers

SORCS3 gene found as a susceptibility gene for panic disorder

Oct. 18, 2022
Panic disorder is defined by recurrent and...
Read More
Neurology/Psychiatric

miR-132-3p silencing alleviates seizures and recurrences in mesial temporal lobe epilepsy

Oct. 18, 2022
Previous research has demonstrated that the...
Read More
Gene editing illustration
Immuno-oncology

EDIT-202: gene-edited iNK cells for cancer immunotherapy

Oct. 18, 2022
Editas Medicine Inc. has reported preclinical...
Read More
Neurology/Psychiatric

ZLWQ-21, novel coumarin derivative and multifunctional candidate for the treatment of AD

Oct. 18, 2022
Investigators from Shenyang Pharmaceutical...
Read More
Brain and DNA
Genetic/Congenital

NGN-401: a new self-regulating gene therapy for Rett syndrome

Oct. 18, 2022
Researchers from the University of Edinburgh in...
Read More
Doctor shows patient anatomy image of prostate on computer.
Diagnostics

Heterodimeric radiotracer [68Ga]Ga-BQ7812 shows efficacy in models of prostate cancer

Oct. 18, 2022
Researchers from Uppsala University have...
Read More
Immune

SYK enzyme modulates microglia in Alzheimer's disease, multiple sclerosis

Oct. 18, 2022
By Mar de Miguel
Tyrosine kinase SYK (spleen tyrosine kinase), an enzyme involved in immune signaling, could play a key role in Alzheimer's disease (AD), multiple sclerosis (MS), and other neurodegenerative diseases, according to a study from the University of Virginia (UVA). SYK regulates the activity of microglia, preventing the accumulation of secretions associated with AD or MS produced in these pathologies.
Read More
Mouse in maze
Neurology/Psychiatric

Complexities of psychiatric animal models on view at ECNP 2022

Oct. 18, 2022
By Anette Breindl
Psychiatric animal models are a challenge by their nature. Whether a drug is blocking tumor growth in a rodent is easy enough to measure, although still hard to translate. But how does one figure out what a mouse is thinking? Actually, one doesn’t. There is “no way in heck I’m going to claim that I can model a thought disorder in rodents, so forget about that,” Bita Moghaddam told her audience at the opening keynote of the European College of Neuropsychopharmacology (ECNP) annual conference this weekend. But other aspects of mental disorders, she argued, can be usefully modeled.
Read More

Other news to note for Oct. 18, 2022

Oct. 18, 2022
Additional early-stage research and drug discovery news in brief, from: Sorrento, Point Biopharma.
Read More
Previous 1 2 … 1276 1277 1278 1279 1280 1281 1282 1283 1284 … 18042 18043 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 15, 2026.
  • MMP inhibitors divulged in Accure Therapeutics patent

    BioWorld Science
    Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 14, 2026
  • Cancer cell in the cross-hairs

    Selective CBL-B inhibitor with improved safety profile disclosed

    BioWorld Science
    CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
  • MSD discloses new HCN1/2 blockers

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing